Abiopharma

News list

Roman Shawn David 🟢 acquired 88.0K shares (1 derivative) of Apyx Medical Corp (APYX) at $4.65 Transaction Date: Jun 11, 2026 | Filing ID: 028769

Full text

News bot June 15, 2026, 11 p.m.
🔍 Roman Shawn David (Executive)

Company: Apyx Medical Corp (APYX)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 88,044
Detailed Transactions and Holdings:
- Acquired 88,044 shares of Stock Option (Option to Buy) at $4.65 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | equity_swap_involved: 0 | shares_owned_after: 88,044.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.